• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations.

作者信息

Matarraz S, Paiva B, Díez-Campelo M, Bárrena S, Jara-Acevedo M, Gutiérrez M L, Sayagués J M, Sánchez M-L, Bárcena P, Garrastazul M P, Berruezo M J, Duran J M, Cerveró C, García-Erce J A, Florensa L, Méndez G D, Gutierrez O, Del Cañizo M C, van Dongen J J M, San Miguel J F, Orfao A

机构信息

Department of Medicine, Centro de Investigación del Cáncer (IBMCC, University of Salamanca-CSIC) and IBSAL, Salamanca, Spain.

Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.

出版信息

Leukemia. 2014 Aug;28(8):1747-50. doi: 10.1038/leu.2014.103. Epub 2014 Mar 14.

DOI:10.1038/leu.2014.103
PMID:24625552
Abstract
摘要

相似文献

1
Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations.多发性骨髓瘤患者骨髓髓样细胞区室的免疫表型改变预示着骨髓发育异常相关的细胞遗传学改变。
Leukemia. 2014 Aug;28(8):1747-50. doi: 10.1038/leu.2014.103. Epub 2014 Mar 14.
2
Clinical implications of immunophenotypic abnormalities of bone marrow myeloid cell compartment in myelodysplastic syndromes.骨髓增生异常综合征中骨髓髓系细胞区室免疫表型异常的临床意义
J BUON. 2010 Oct-Dec;15(4):746-52.
3
Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide?骨髓瘤患者骨髓细胞中骨髓增生异常相关免疫表型改变：这些改变是在诊断时存在还是由来那度胺诱导的？
Haematologica. 2012 Oct;97(10):1608-11. doi: 10.3324/haematol.2012.064121. Epub 2012 Apr 17.
4
Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.比较骨髓中红系细胞比例超过 50%的急性髓系白血病和骨髓增生异常综合征患者的遗传和临床特征。
Haematologica. 2011 Sep;96(9):1284-92. doi: 10.3324/haematol.2011.043687. Epub 2011 May 23.
5
[Study on the immunophenotype of myeloid cells in myelodysplastic syndromes and its clinical implications].骨髓增生异常综合征中髓系细胞免疫表型及其临床意义的研究
Zhonghua Xue Ye Xue Za Zhi. 1997 Feb;18(2):80-3.
6
Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome.流式细胞术免疫表型分析在骨髓增生异常综合征中的诊断效用
Blood. 2001 Aug 15;98(4):979-87. doi: 10.1182/blood.v98.4.979.
7
Cytogenetic abnormalities in acute leukemia complicating melphalan-treated multiple myeloma.美法仑治疗的多发性骨髓瘤并发急性白血病中的细胞遗传学异常
Cancer Genet Cytogenet. 1990 Aug 1;48(1):67-73. doi: 10.1016/0165-4608(90)90218-y.
8
Transient myelodysplasia in an infant with Down syndrome preceding acute megakaryoblastic leukemia: cytogenetic and immunophenotypic findings.
Cancer Genet Cytogenet. 2009 Jan 1;188(1):54-6. doi: 10.1016/j.cancergencyto.2008.09.003.
9
Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoring.伴有5号染色体长臂缺失的骨髓增生异常综合征表现出适合诊断和反应监测的特征性免疫表型谱。
Haematologica. 2015 Mar;100(3):e93-6. doi: 10.3324/haematol.2014.115725. Epub 2014 Nov 25.
10
Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes.联合免疫表型分析与DNA原位杂交研究骨髓增生异常综合征患者的谱系受累情况。
Blood. 1992 Apr 1;79(7):1823-8.

引用本文的文献

1
Second malignancies in multiple myeloma; emerging patterns and future directions.多发性骨髓瘤中的第二恶性肿瘤；新兴模式和未来方向。
Best Pract Res Clin Haematol. 2020 Mar;33(1):101144. doi: 10.1016/j.beha.2020.101144. Epub 2020 Jan 11.
2
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group.骨髓增生异常综合征中红系发育异常的免疫表型分析。来自IMDSFlow工作组的报告。
Haematologica. 2017 Feb;102(2):308-319. doi: 10.3324/haematol.2016.147835. Epub 2016 Oct 6.
3
Altered neutrophil immunophenotypes in childhood B‑cell precursor acute lymphoblastic leukemia.

本文引用的文献

1
Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma.总治疗 2 和 3 后多发性骨髓瘤患者发生骨髓增生异常综合征和急性白血病的危险因素。
Blood. 2013 Jun 6;121(23):4753-7. doi: 10.1182/blood-2012-11-466961. Epub 2013 Apr 19.
2
Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis.新诊断的成人 AML 和 MPAL 患者常表现为克隆性残留造血。
Leukemia. 2013 Nov;27(11):2149-56. doi: 10.1038/leu.2013.109. Epub 2013 Apr 12.
3
Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients.
儿童B细胞前体急性淋巴细胞白血病中中性粒细胞免疫表型的改变
Oncotarget. 2016 Apr 26;7(17):24664-76. doi: 10.18632/oncotarget.8369.
4
Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow.多发性骨髓瘤浸润骨髓中与 APRIL 持续产生相关的髓系细胞生成失调。
Leukemia. 2015 Sep;29(9):1901-8. doi: 10.1038/leu.2015.68. Epub 2015 Mar 10.
意义未明的单克隆丙种球蛋白血症（MGUS）患者发生急性白血病和骨髓增生异常综合征的风险：对 17315 例患者的基于人群的研究。
Leukemia. 2013 Jun;27(6):1391-3. doi: 10.1038/leu.2013.34. Epub 2013 Feb 5.
4
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols.EuroFlow 流式细胞仪仪器设置和免疫表型分析协议的标准化。
Leukemia. 2012 Sep;26(9):1986-2010. doi: 10.1038/leu.2012.122.
5
Second to none.首屈一指。
Blood. 2012 Aug 23;120(8):1537-9. doi: 10.1182/blood-2012-07-439158.
6
Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?多发性骨髓瘤的连续 Total Therapy 试验改善了长期结果：患者现在是否被治愈了？
Leukemia. 2013 Jan;27(1):226-32. doi: 10.1038/leu.2012.160. Epub 2012 Jun 18.
7
Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance.新诊断多发性骨髓瘤的总治疗 2 和 3 中的第二恶性肿瘤：维持治疗期间沙利度胺和来那度胺的影响。
Blood. 2012 Aug 23;120(8):1597-600. doi: 10.1182/blood-2012-04-421883. Epub 2012 Jun 6.
8
Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.来那度胺维持治疗多发性骨髓瘤患者干细胞移植后。
N Engl J Med. 2012 May 10;366(19):1782-91. doi: 10.1056/NEJMoa1114138.
9
Lenalidomide after stem-cell transplantation for multiple myeloma.来那度胺用于多发性骨髓瘤患者干细胞移植后。
N Engl J Med. 2012 May 10;366(19):1770-81. doi: 10.1056/NEJMoa1114083.
10
Continuous lenalidomide treatment for newly diagnosed multiple myeloma.来那度胺持续治疗新诊断的多发性骨髓瘤。
N Engl J Med. 2012 May 10;366(19):1759-69. doi: 10.1056/NEJMoa1112704.